3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
13
Thoracic
1
Other hematologic neoplasm
1
Other
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
CNS
1
Breast
1
Conditions
Uterine Cervical Neoplasms
9
Breast Neoplasms
6
Ovarian Neoplasms
5
Prostatic Neoplasms
3
Papillomavirus Infections
3
Endometrial Neoplasms
3
Triple Negative Breast Neoplasms
2
Genital Neoplasms, Female
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Stage IB Cervical Cancer FIGO 2018
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Lung Neoplasms
1
Kidney Neoplasms
1
Gynecologic Cancer
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Disease
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Paclitaxel
28
Carboplatin
28
pembrolizumab
25
Bevacizumab
14
liposomal doxorubicin
12
Cisplatin
11
Gemcitabine
10
Radiotherapy
8
Drug Therapy
8
Cyclophosphamide
8
Blood Specimen Collection
8
Topotecan
7
Nivolumab
7
olaparib
6
Doxorubicin
6
niraparib
5
Therapeutics
5
Dexamethasone
5
pertuzumab
4
pazopanib
4
lenvatinib
4
fludarabine
4
cemiplimab
4
atezolizumab
4
Trastuzumab
4
Surveys and Questionnaires
4
Psychiatric Rehabilitation
4
Polymerase Chain Reaction
4
Fulvestrant
4
Docetaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Educational Status
×
Gynecologic
×
Clear all
NCT04679675
2023-09-18
STEP
Kaiser Permanente
Phase NA
Completed
32,771 enrolled
11 charts